Cancer management in man: biological response modifiers, chemotherapy, antibiotics, hyperthermia, supporting measures
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Dordrecht u.a.
Kluwer
1989
|
| Schriftenreihe: | Cancer growth and progression
10 |
| Schlagworte: | |
| Beschreibung: | X, 248 S. Ill. |
| ISBN: | 0898389992 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV002474959 | ||
| 003 | DE-604 | ||
| 005 | 20130705 | ||
| 007 | t | ||
| 008 | 900207s1989 a||| |||| 00||| engod | ||
| 020 | |a 0898389992 |9 0-89838-999-2 | ||
| 035 | |a (OCoLC)18326502 | ||
| 035 | |a (DE-599)BVBBV002474959 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-355 | ||
| 050 | 0 | |a RC270.8 | |
| 082 | 0 | |a 616.99/406 |2 19 | |
| 084 | |a XH 1100 |0 (DE-625)152865: |2 rvk | ||
| 245 | 1 | 0 | |a Cancer management in man |b biological response modifiers, chemotherapy, antibiotics, hyperthermia, supporting measures |c ed. by Paul V. Woolley |
| 264 | 1 | |a Dordrecht u.a. |b Kluwer |c 1989 | |
| 300 | |a X, 248 S. |b Ill. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Cancer growth and progression |v 10 | |
| 650 | 4 | |a Antineoplastic Agents | |
| 650 | 4 | |a Biological response modifiers |x Therapeutic use |v Congresses | |
| 650 | 4 | |a Cancer |x Adjuvant treatment |v Congresses | |
| 650 | 4 | |a Cancer |x Chemotherapy |v Congresses | |
| 650 | 4 | |a Cancer |x Immunotherapy |v Congresses | |
| 650 | 4 | |a Cancer |x Treatment |v Congresses | |
| 650 | 4 | |a Neoplasms |x drug therapy | |
| 650 | 4 | |a Neoplasms |x therapy | |
| 650 | 0 | 7 | |a Chemotherapie |0 (DE-588)4127083-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Immuntherapie |0 (DE-588)4026640-0 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 0 | 1 | |a Immuntherapie |0 (DE-588)4026640-0 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 1 | 1 | |a Chemotherapie |0 (DE-588)4127083-6 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Woolley, Paul V. |e Sonstige |4 oth | |
| 830 | 0 | |a Cancer growth and progression |v 10 |w (DE-604)BV002430786 |9 10 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-001597479 | ||
Datensatz im Suchindex
| _version_ | 1804116886198157312 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV002474959 |
| callnumber-first | R - Medicine |
| callnumber-label | RC270 |
| callnumber-raw | RC270.8 |
| callnumber-search | RC270.8 |
| callnumber-sort | RC 3270.8 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | XH 1100 |
| ctrlnum | (OCoLC)18326502 (DE-599)BVBBV002474959 |
| dewey-full | 616.99/406 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/406 |
| dewey-search | 616.99/406 |
| dewey-sort | 3616.99 3406 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01920nam a2200529 cb4500</leader><controlfield tag="001">BV002474959</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20130705 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">900207s1989 a||| |||| 00||| engod</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0898389992</subfield><subfield code="9">0-89838-999-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)18326502</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV002474959</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC270.8</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/406</subfield><subfield code="2">19</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 1100</subfield><subfield code="0">(DE-625)152865:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cancer management in man</subfield><subfield code="b">biological response modifiers, chemotherapy, antibiotics, hyperthermia, supporting measures</subfield><subfield code="c">ed. by Paul V. Woolley</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Dordrecht u.a.</subfield><subfield code="b">Kluwer</subfield><subfield code="c">1989</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">X, 248 S.</subfield><subfield code="b">Ill.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Cancer growth and progression</subfield><subfield code="v">10</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic Agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biological response modifiers</subfield><subfield code="x">Therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Adjuvant treatment</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Chemotherapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Immunotherapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Treatment</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">therapy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Immuntherapie</subfield><subfield code="0">(DE-588)4026640-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Immuntherapie</subfield><subfield code="0">(DE-588)4026640-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Woolley, Paul V.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Cancer growth and progression</subfield><subfield code="v">10</subfield><subfield code="w">(DE-604)BV002430786</subfield><subfield code="9">10</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-001597479</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV002474959 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T15:45:38Z |
| institution | BVB |
| isbn | 0898389992 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-001597479 |
| oclc_num | 18326502 |
| open_access_boolean | |
| owner | DE-12 DE-355 DE-BY-UBR |
| owner_facet | DE-12 DE-355 DE-BY-UBR |
| physical | X, 248 S. Ill. |
| publishDate | 1989 |
| publishDateSearch | 1989 |
| publishDateSort | 1989 |
| publisher | Kluwer |
| record_format | marc |
| series | Cancer growth and progression |
| series2 | Cancer growth and progression |
| spelling | Cancer management in man biological response modifiers, chemotherapy, antibiotics, hyperthermia, supporting measures ed. by Paul V. Woolley Dordrecht u.a. Kluwer 1989 X, 248 S. Ill. txt rdacontent n rdamedia nc rdacarrier Cancer growth and progression 10 Antineoplastic Agents Biological response modifiers Therapeutic use Congresses Cancer Adjuvant treatment Congresses Cancer Chemotherapy Congresses Cancer Immunotherapy Congresses Cancer Treatment Congresses Neoplasms drug therapy Neoplasms therapy Chemotherapie (DE-588)4127083-6 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Immuntherapie (DE-588)4026640-0 gnd rswk-swf (DE-588)1071861417 Konferenzschrift gnd-content Krebs Medizin (DE-588)4073781-0 s Immuntherapie (DE-588)4026640-0 s DE-604 Chemotherapie (DE-588)4127083-6 s Woolley, Paul V. Sonstige oth Cancer growth and progression 10 (DE-604)BV002430786 10 |
| spellingShingle | Cancer management in man biological response modifiers, chemotherapy, antibiotics, hyperthermia, supporting measures Cancer growth and progression Antineoplastic Agents Biological response modifiers Therapeutic use Congresses Cancer Adjuvant treatment Congresses Cancer Chemotherapy Congresses Cancer Immunotherapy Congresses Cancer Treatment Congresses Neoplasms drug therapy Neoplasms therapy Chemotherapie (DE-588)4127083-6 gnd Krebs Medizin (DE-588)4073781-0 gnd Immuntherapie (DE-588)4026640-0 gnd |
| subject_GND | (DE-588)4127083-6 (DE-588)4073781-0 (DE-588)4026640-0 (DE-588)1071861417 |
| title | Cancer management in man biological response modifiers, chemotherapy, antibiotics, hyperthermia, supporting measures |
| title_auth | Cancer management in man biological response modifiers, chemotherapy, antibiotics, hyperthermia, supporting measures |
| title_exact_search | Cancer management in man biological response modifiers, chemotherapy, antibiotics, hyperthermia, supporting measures |
| title_full | Cancer management in man biological response modifiers, chemotherapy, antibiotics, hyperthermia, supporting measures ed. by Paul V. Woolley |
| title_fullStr | Cancer management in man biological response modifiers, chemotherapy, antibiotics, hyperthermia, supporting measures ed. by Paul V. Woolley |
| title_full_unstemmed | Cancer management in man biological response modifiers, chemotherapy, antibiotics, hyperthermia, supporting measures ed. by Paul V. Woolley |
| title_short | Cancer management in man |
| title_sort | cancer management in man biological response modifiers chemotherapy antibiotics hyperthermia supporting measures |
| title_sub | biological response modifiers, chemotherapy, antibiotics, hyperthermia, supporting measures |
| topic | Antineoplastic Agents Biological response modifiers Therapeutic use Congresses Cancer Adjuvant treatment Congresses Cancer Chemotherapy Congresses Cancer Immunotherapy Congresses Cancer Treatment Congresses Neoplasms drug therapy Neoplasms therapy Chemotherapie (DE-588)4127083-6 gnd Krebs Medizin (DE-588)4073781-0 gnd Immuntherapie (DE-588)4026640-0 gnd |
| topic_facet | Antineoplastic Agents Biological response modifiers Therapeutic use Congresses Cancer Adjuvant treatment Congresses Cancer Chemotherapy Congresses Cancer Immunotherapy Congresses Cancer Treatment Congresses Neoplasms drug therapy Neoplasms therapy Chemotherapie Krebs Medizin Immuntherapie Konferenzschrift |
| volume_link | (DE-604)BV002430786 |
| work_keys_str_mv | AT woolleypaulv cancermanagementinmanbiologicalresponsemodifierschemotherapyantibioticshyperthermiasupportingmeasures |